Table 2.
Population screened | Β-thalassemia Trait | Sickle Cell Trait | |||||
---|---|---|---|---|---|---|---|
Year | 12,30,582 | Positive test | PR* | 95% Confidence Interval | Positive test | PR | 95% Confidence Interval |
2011 | 78,072 | 1892 | 24.2 | 23.2–25.3 | 3304 | 42.3 | 41.0–43.8 |
2012 | 2,58,581 | 4557 | 17.7 | 17.1–18.2 | 13,055 | 50.5 | 49.7–51.3 |
2013 | 2,68,097 | 2837 | 10.6 | 10.2–11.0 | 13,406 | 50.0 | 49.2–50.8 |
2014 | 2,76,236 | 2666 | 9.7 | 9.3–10.0 | 13,490 | 48.9 | 48.0–49.7 |
2015 | 3,05,871 | 3657 | 12.0 | 11.6–12.4 | 15,307 | 50.0 | 49.3–50.8 |
[2] Incebiyik A, Genc A, Hilali NG, Camuzcuoglu A, Camuzcuoglu H, Kilic A, Vural M. Prevalence of beta-thalassemia trait and abnormal hemoglobins in Sanliurfa Province in southeast Turkey. Hemoglobin 2014;38(6):402–404. doi: 10.3109/03630269.2014.978008. PubMed PMID: 25405917.
p-value <0.0001 for comparisons of PRs for β-thalassemia carrier by year [2].